IL6 and inflammatory bowel disease: Studies have indicated that the level of proinflammatory cytokines, IL-1β and IL-6, descended significantly in inflammatory bowel disease 39, acute pancreatitis 40 and type 2 diabetes 17 after injection of HUMSCs.